iShares Biotechnology ETF (IBB)

132.73 +1.52 (+1.16%) USD  |  NASDAQ  |  Dec 20, 16:00
132.73 0.00 (0.00%) After-Hours: 20:00
More

IBB Beta (Since Inception)

Beta (Since Inception) Chart

View Beta (Since Inception) for IBB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Beta (Since Inception) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Beta Definition

View Beta Definition
Start Trial

Beta is a risk metric that measures the risk associated with a security in comparison to the risk associated with the market overall. A beta of 1 would signify that the beta is neutral with the market. A common use of beta is within the Capital Asset Pricing Model (CAPM), to find a security's expected return.

Read full definition.

Beta (Since Inception) Range, Past 5 Years

View Beta (Since Inception) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Beta (Since Inception) Benchmarks

View Beta (Since Inception) Benchmarks
Start Trial
First Trust Health Care AlphaDEX Fund Upgrade
iShares US Medical Devices ETF Upgrade
First Trust NYSE Arca Biotechnology Index Fund Upgrade
WisdomTree BioRevolution Fund Upgrade
Invesco Nasdaq Biotechnology ETF Upgrade

Beta (Since Inception) Related Metrics

Alpha (Since Inception) Upgrade
Alpha (vs YCharts Benchmark) (Since Inception) Upgrade
Beta (vs YCharts Benchmark) (Since Inception) Upgrade
Annualized Standard Deviation of Monthly Returns (Since Inception) Upgrade
Historical Sharpe Ratio (Since Inception) Upgrade
Historical Sortino (Since Inception) Upgrade
Max Drawdown (Since Inception) Upgrade
Monthly Value at Risk (VaR) 5% (Since Inception) Upgrade